Literature DB >> 7890649

Identification of the membrane attachment sites for protein 4.1 in the human erythrocyte.

N J Hemming1, D J Anstee, M A Staricoff, M J Tanner, N Mohandas.   

Abstract

The nature of the membrane attachment site(s) for protein 4.1 in the human erythrocyte membrane has yet to be fully elucidated. In this paper we show that the major attachment site is glycophorin (GP) C/D, and that purified protein 4.1 can bind to two distinct sites on glycophorin C/D. One of these interactions is direct, involving residues 82-98 on glycophorin C (61-77 on glycophorin D), while the other interaction is mediated by p55. We have localized the binding site for p55 on glycophorin C to residues 112-128 (glycophorin D91-107). We also provide evidence that band 3 is an additional, minor, protein 4.1 binding site. The binding sites for band 3, glycophorin C/D, and p55 are all located within the 30-kDa domain of protein 4.1. We estimate that the relative utilization of the three sites in normal membranes comprises 40% to p55, 40% to GPC/D, and 20% to band 3. The same region of protein 4.1 binds GPC/D and band 3, while the p55 binding site is distinct. The interactions involving protein 4.1 with p55 and p55 with GPC/D are of high affinity (nM), while those involving GPC/D and band 3 are 100-fold lower (microM). These results suggest that the most significant interactions between protein 4.1 and the membrane are those involving p55.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890649     DOI: 10.1074/jbc.270.10.5360

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Elasticity of the red cell membrane and its relation to hemolytic disorders: an optical tweezers study.

Authors:  J Sleep; D Wilson; R Simmons; W Gratzer
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Mapping of a palmitoylatable band 3-binding domain of human erythrocyte membrane protein 4.2.

Authors:  R Bhattacharyya; A K Das; P K Moitra; B Pal; I Mandal; J Basu
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

3.  Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R.

Authors:  P Gascard; W Nunomura; G Lee; L D Walensky; S W Krauss; Y Takakuwa; J A Chasis; N Mohandas; J G Conboy
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

4.  Mapping of an ankyrin-sensitive, phosphatidylethanolamine/phosphatidylcholine mono- and bi-layer binding site in erythroid beta-spectrin.

Authors:  Anita Hryniewicz-Jankowska; Ewa Bok; Patrycja Dubielecka; Anna Chorzalska; Witold Diakowski; Adam Jezierski; Marek Lisowski; Aleksander F Sikorski
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

5.  Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor.

Authors:  K Ye; D A Compton; M M Lai; L D Walensky; S H Snyder
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

6.  Cytoskeletal protein 4.1G binds to the third intracellular loop of the A1 adenosine receptor and inhibits receptor action.

Authors:  Dongcheng Lu; Henglin Yan; Timothy Othman; Christopher P Turner; Thomas Woolf; Scott A Rivkees
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

Review 7.  The proteome of sickle cell disease: insights from exploratory proteomic profiling.

Authors:  Susan Yuditskaya; Anthony F Suffredini; Gregory J Kato
Journal:  Expert Rev Proteomics       Date:  2010-12       Impact factor: 3.940

Review 8.  Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling.

Authors:  Mark D Bass; Martin J Humphries
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

9.  Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site.

Authors:  Massimiliano Gaetani; Sara Mootien; Sandra Harper; Patrick G Gallagher; David W Speicher
Journal:  Blood       Date:  2008-01-24       Impact factor: 22.113

10.  4.1R-deficient human red blood cells have altered phosphatidylserine exposure pathways and are deficient in CD44 and CD47 glycoproteins.

Authors:  Kris P Jeremy; Zoe E Plummer; David J Head; Tracey E Madgett; Kelly L Sanders; Amanda Wallington; Jill R Storry; Florinda Gilsanz; Jean Delaunay; Neil D Avent
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.